Premium
Impact of chemotherapy‐induced alopecia distress on body image, psychosocial well‐being, and depression in breast cancer patients
Author(s) -
Choi Eun Kyung,
Kim ImRyung,
Chang Oliver,
Kang Danbee,
Nam SeokJin,
Lee Jeong Eon,
Lee Se Kyung,
Im YoungHyuck,
Park Yeon Hee,
Yang JungHyun,
Cho Juhee
Publication year - 2014
Publication title -
psycho‐oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.41
H-Index - 137
eISSN - 1099-1611
pISSN - 1057-9249
DOI - 10.1002/pon.3531
Subject(s) - psychosocial , breast cancer , distress , medicine , depression (economics) , quality of life (healthcare) , cancer , chemotherapy , psychiatry , clinical psychology , nursing , economics , macroeconomics
Purpose This study aims to evaluate the impact of chemotherapy‐induced alopecia (CIA) distress on body image, psychosocial well‐being, and depression among breast cancer patients. Methods A cross‐sectional survey was conducted at the breast cancer advocacy events held at 16 hospitals in Korea. Alopecia distress was assessed using the ‘Chemotherapy‐Induced Alopecia Distress Scale’, body image and psychosocial well‐being were measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and breast specific module (BR23), and depression was measured using the Center for Epidemiological Studies Depression scale. Means of outcomes were compared between low and high CIA distress groups. Univariable and multivariable linear regression models were used to analyze the relationship between the CIA distress and body image, psychosocial well‐being, and depression. Results One hundred sixty‐eight breast cancer patients participated in the study; the mean age was 48.4 (SD = 8.4) years, and 55.3% of the patients experienced higher distress from alopecia. In fully adjusted models, the high distress group was more likely to have a poorer body image than the low distress group (35.2 vs. 62.0; p < 0.001). Distressed patients were also more likely to report lower emotional (55.3 vs. 76.9; p < 0.001), role (58.6 vs. 72.0; p < 0.001), and social functioning (51.3 vs. 70.9; p < 0.001). The high distress group was also more likely to have depression compared with the low distress group (19.6 vs. 14.8; p < 0.001). Conclusions Chemotherapy‐induced alopecia distress was negatively associated with body image, psychosocial well‐being, and depression in women with breast cancer. It is necessary to develop specific interventions to minimize distress due to alopecia for women with breast cancer. Copyright © 2014 John Wiley & Sons, Ltd.